| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5725258 | Revue des Maladies Respiratoires Actualités | 2016 | 4 Pages |
Abstract
The treatment is based on the corticoteroids during the acute phase and on specific treatment (Cyclophosphamide or Rituximab) for immune diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
C. Goyard, J. Cadranel,